The project titled “Commercial First Artificial Cornea Production,” jointly conducted by Marmara University Nanotechnology and Biomaterials Application and Research Center (NBUAM) and VSY Biotechnology and Pharmaceutical Industry Inc., has been deemed eligible for support within the scope of the TÜBİTAK 1505 University–Industry Cooperation Program. This acceptance marks the first university-industry cooperation project in the field of artificial cornea production in Turkey to be supported under the TÜBİTAK 1505 program.

Keratoconus is an eye disease that causes severe vision loss due to the thinning and conical deformation of the cornea, with limited treatment options in advanced stages. While synthetic corneal rings used in current treatments have limitations due to the risks of infection and tissue rejection, CAIRS rings produced from donor tissue also have significant constraints in terms of widespread and sustainable use. Factors such as insufficient donor tissue, the risk of rejection, and cost increase the need for new and accessible solutions in this field.

Within the scope of the project, NBUAM researchers aim to develop a commercially viable artificial cornea that eliminates donor dependency by using 3D bioprinting technology and an innovative hybrid bioink. This new approach is expected to facilitate access to treatment, offer physicians a cost-accessible product, and reduce the risk of complications.